Self-Expandable Stents Market: Current Analysis and Forecast (2023-2030)

Self-expandable stents are medical devices used primarily in the field of interventional cardiology and vascular surgery to treat narrowed or blocked blood vessels. Unlike balloon-expandable stents that require inflation to deploy, self-expandable stents are designed to expand automatically upon insertion into the targeted vessel. This property makes them particularly useful in regions of the body where vessels are subject to movement or variation in diameter. The rising incidence of cardiovascular disorders, such as PAD and CAD, fuel the demand for interventional therapies like stent implantation, contributing to market expansion. For instance, as per the data of Certers for Disease Control and Prevention, 60% of the Amaercans are living with atleast one of the chronic disorder like heart disease, diabetes, or cancer. Further, about 650,000 deaths related to heart diasese were reported in United States during year 2021.

The Self-expandable Stents Market was valued at USD 3,200 Million in 2022 and is expected to grow at a CAGR of around 7.5% from 2023-2030.

Based on the product, the market is segmented into Carotid Self-expanding Stents, Gastrointestinal Self-expanding Stents, Endovascular Self-expandable Stents, and Others. The carotid self-expanding stents segment held the largest market share in 2022. Rising incidence of coronary artery disorders such as carotid artery stenosis etc. is acting as one of the major driver for the market.

On the basis of application, the market is categorized into Fem-Pop Artery, iliac Artery, Carotid Artery, Biliary, and Other. Among these, significant growth is observed in the carotid artery application which is mainly due to increasing adoption of carotid artery stenting (CAS) as an treatment option for carotid artery disease.

On the basis of end user, the market is categorized into Hospitals, Ambulatory Surgical Centers, and Others. Among these, exponential growth is observed in the ambulatory surgical centers which is mainly due to substantial presence of ambulatory surgical centers in various geographies and increasing preference of patients towards the ambulatory surgical centers for stenting related procedures.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Self-expandable Stents Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of cardiovascular disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Boston Scientific Corporation, Medtronic, Cordis, Cook Medical, Biotronik, Inc., Abbott, BD Interventional, Merit Medical Systems, Inc., Terumo Corporation, and Veryan Medical.